Obecne zalecenia dotyczące postępowania w zwężeniu tętnicy nerkowej a wyniki badania CORAL Artykuł przeglądowy

##plugins.themes.bootstrap3.article.main##

Łukasz Artyszuk

Abstrakt

Zwężenie tętnicy nerkowej (ZTN) może być przyczyną niewydolności nerek i nadciśnienia tętniczego. Prospektywne, randomizowane badania dowiodły, że ZTN zwiększa ryzyko sercowo-naczyniowe, nerkowe i zgonu. Dotychczasowe dane pokazują, iż leczenie farmakologiczne nie jest wystarczająco skuteczne, a leczenie inwazyjne wzbudza wiele kontrowersji. Wieloośrodkowe, prospektywne badania, w tym opublikowane ostatnio badanie CORAL, nie dowiodły korzyści z rewaskularyzacji jako uzupełnienia leczenia farmakologicznego. Wyniki tych badań będą miały istotny wpływ na kształtowanie wytycznych dotyczących postępowania w ZTN.

Pobrania

Dane pobrania nie są jeszcze dostepne

##plugins.themes.bootstrap3.article.details##

Jak cytować
Artyszuk , Łukasz. (2014). Obecne zalecenia dotyczące postępowania w zwężeniu tętnicy nerkowej a wyniki badania CORAL . Kardiologia W Praktyce, 8(1), 9-16. Pobrano z https://journalsmededu.pl/index.php/kwp/article/view/1540
Dział
Artykuły

Bibliografia

1. Kaatee R., Beek F.J., Verschuyl E.J. et al.: Atherosclerotic renal artery stenosis: ostial or truncal? Radiology 1996; 199(3): 637-640.
2. Safian R.D., Textor S.C.: Renal-artery stenosis. N. Engl. J. Med. 2001; 344(6): 431-442.
3. Maxwell M.H., Bleifer K.H., Franklin S.S. et al.: Cooperative study of renovascular hypertension. Demographic analysis of the study. JAMA 1972; 220(9): 1195-1204.
4. Detection, evaluation, and treatment of renovascular hypertension. Final report. Working Group on Renovascular Hypertension. Arch. Intern. Med. 1987; 147(5): 820-829.
5. Sang C.N., Whelton P.K., Hamper U. et al.: Etiologic factors of renovascular fibromuscular dysplasia: A case-controlled study. Hypertension 1989; 14: 472-479.
6. Tegtmeyer C.J., Selby J.B., Hartwell G.D. et al.: Results and complications of angioplasty in fibromuscular disease. Circulation 1991; 83(supl. I): I155-161.
7. Simon N., Franklin S.S., Bleifer K.H. et al.: Clinical characteristics of renovascular hypertension. JAMA 1972; 220(9): 1209-1218.
8. Ram C.V.: Renovascular hypertension. Curr. Opin. Nephrol. Hypertens. 1997; 6(6): 575-579.
9. Vokonas P.S., Kannel W.B., Cupples L.A.: Epidemiology and risk of hypertension in the elderly: the Framingham Study. J. Hypertens. Suppl. 1988; 6(1): S3-9.
10. Guo, H., Kalra P.A., Gilbertson D.T. et al.: Atherosclerotic renovascular disease in older US patients starting dialysis, 1996 to 2001. Circulation 2007; 115(1): 50-58.
11. Börgel J., Springer S., Ghafoor J. et al.: Unrecognized secondary causes of hypertension in patients with hypertensive urgency/emergency: prevalence and co-prevalence. Clin. Res. Cardiol. 2010; 99: 499-506.
12. Crowley J.J., Santos R.M., Peter R.H. et al.: Progression of renal artery stenosis in patients undergoing cardiac catheterization. Am. Heart J. 1998; 136(5): 913-918.
13. Harding M.B., Smith L.R., Himmelstein S.I. et al.: Renal artery stenosis: prevalence and associated risk factors in patients undergoing routine cardiac catheterization. J. Am. Soc. Nephrol. 1992; 2(11): 1608-1616.
14. Dzielinska Z., Januszewicz A., Demkow M. et al.: Cardiovascular risk factors in hypertensive patients with coronary artery disease and coexisting renal artery stenosis. J. Hypertens. 2007; 25(3): 663-670.
15. Hansen K.J., Edwards M.S., Craven T.E. et al.: Prevalence of renovascular disease in the elderly: a population-based study. J. Vasc. Surg. 2002; 36(3): 443-451.
16. Caps M.T., Perissinotto C., Zierler R.E. et al.: Prospective study of atherosclerotic disease progression in the renal artery. Circulation 1998; 98(25): 2866-2872.
17. Greco B.A., Breyer J.A.: The natural history of renal artery stenosis: who should be evaluated for suspected ischemic nephropathy? Semin. Nephrol. 1996; 16(1): 2-11.
18. Goldblatt H., Lynch J., Hanzal R.F. et al.: Studies on experimental hypertension. I. The production of persistent elevation of systolic blood pressure by means of renal ischemia. J. Exp. Med. 1934; 59: 69-103.
19. Goldblatt H.: The renal origin of hypertension. Physiol. Rev. 1947; 27: 120-165.
20. Harding M.B., Smith L.R., Himmelstein S.I. et al.: Renal artery stenosis: prevalence and associated risk factors in patients undergoing routine cardiac catheterization. J. Am. Soc. Nephrol. 1992; 2(11): 1608-1616.
21. Edwards M.S., Craven T.E., Burke G.L. et al.: Renovascular disease and the risk of adverse coronary events in the elderly: a prospective, population-based study. Arch. Intern. Med. 2005; 165(2): 207-213.
22. Olin J.W., Melia M., Young J.R. et al.: Prevalence of atherosclerotic renal artery stenosis in patients with atherosclerosis elsewhere. Am. J. Med. 1990; 88: 46N-51N.
23. Kalra P.A., Guo H., Kausz A.T. et al.: Atherosclerotic renovascular disease in United States patients aged 67 years or older: risk factors, revascularization, and prognosis. Kidney Int. 2005; 68(1): 293-301.
24. Dean R.H., Kieffer R.W., Smith B.M. et al.: Renovascular hypertension: anatomic and renal function changes during drug therapy. Arch. Surg. 1981; 116(11): 1408-1415.
25. Safak E., Wilke C., Derer W. et al.: Long-term follow-up of patients with atherosclerotic renal artery disease. J. Am. Soc. Hypertens. 2013; 7(1): 24-31.
26. Conlon P.J., Athirakul K., Kovalik E. et al.: Survival in renal vascular disease. J. Am. Soc. Nephrol. 1998; 9(2): 252-256.
27. Mui KW, Sleeswijk M., van den Hout H. et al.: Incidental renal artery stenosis is an independent predictor of mortality in patients with peripheral vascular disease. J. Am. Soc. Nephrol. 2006; 17(7): 2069-2074.
28. Chabova V., Schirger A., Stanson A.W. et al.: Outcomes of atherosclerotic renal artery stenosis managed without revascularization. Mayo Clin. Proc. 2000; 75(5): 437-444.
29. Harden P.N., MacLeod M.J., Rodger R.S. et al.: Effect of renal-artery stenting on progression of renovascular renal failure. Lancet 1997; 349: 1133-1136.
30. Watson P.S., Hadjipetrou P., Cox S.V. et al.: Effect of renal artery stenting on renal function and size in patients with atherosclerotic renovascular disease. Circulation 2000; 102: 1671-1677.
31. Burket M.W., Cooper C.J., Kennedy D.J. et al.: Renal artery angioplasty and stent placement: predictors of a favorable outcome. Am. Heart J. 2000; 139: 64-71.
32. Lederman R.J., Mendelsohn F.O., Santos R. et al.: Primary renal artery stenting: characteristics and outcomes after 363 procedures. Am. Heart J. 2001; 142(2): 314-323.
33. Blum U., Krumme B., Flügel P. et al.: Treatment of ostial renal-artery stenosis with vascular endoprostheses after unsuccessful balloon angioplasty. N. Engl. J. Med. 1997; 336: 459-465.
34. Dorros G., Jaff M., Mathiak L. et al.: Four-year follow-up of Palmaz-Schatz stent revascularization as treatment for atherosclerotic renal artery stenosis. Circulation 1998; 98(7): 642-647.
35. Leertouwer T.C., Gussenhoven E.J., Bosch J.L. et al.: Stent placement for renal arterial stenosis: where do we stand? A meta-analysis. Radiology 2000; 216(1): 78-85.
36. van de Ven P.J., Kaatee R., Beutler J.J. et al.: Arterial stenting and balloon angioplasty in ostial atherosclerotic renovascular disease: a randomised trial. Lancet 1999; 353: 282-286.
37. Webster J., Marshall F., Abdalla M. et al.: Randomised comparison of percutaneous angioplasty vs continued medical therapy for hypertensive patients with atheromatous renal artery stenosis. Scottish and Newcastle Renal Artery Stenosis Collaborative Group. J. Hum. Hypertens. 1998; 12: 329-335.
38. Plouin P.F., Chatellier G., Darné B. et al.: Blood pressure outcome of angioplasty in atherosclerotic renal artery stenosis: a randomized trial. Essai Multicentrique Medicaments vs Angioplastie (EMMA) Study Group. Hypertension 1998; 31: 823-829.
39. van Jaarsveld B.C., Krijnen P., Pieterman H. et al.: The effect of balloon angioplasty on hypertension in atherosclerotic renal-artery stenosis. Dutch Renal Artery Stenosis Intervention Cooperative Study Group. N. Engl. J. Med. 2000; 342: 1007-1014.
40. Ives N.J., Wheatley K., Stowe R.L. et al.: Continuing uncertainty about the value of percutaneous revascularization in atherosclerotic renovascular disease: a meta-analysis of randomized trials. Nephrol. Dial. Transplant. 2003; 18: 298-304.
41. Bax L., Woittiez A.J.J., Kouwenberg H.J. et al.: Stent placement in patients with atherosclerotic renal artery stenosis and impaired renal function: a randomized trial. Ann. Intern. Med. 2009; 150: 840-848, W150-1.
42. Wheatley K., Ives N. et al.: ASTRAL Investigators; Revascularization versus medical therapy for renal-artery stenosis. N. Engl. J. Med. 2009; 361: 1953-1962.
43. Kane G.C., Xu N., Mistrik E. et al.: Renal artery revascularization improves heart failure control in patients with atherosclerotic renal artery stenosis. Nephrol. Dial. Transplant. 2010; 25: 813-820.
44. Cooper C.J., Murphy T.P., Cutlip D.E. et al.: Stenting and medical therapy for atherosclerotic renal-artery stenosis. N. Engl. J. Med. 2014; 370: 13-22.
45. Trinquart L., Mounier-Vehier C., Sapoval M. et al.: Efficacy of revascularization for renal artery stenosis caused by fibromuscular dysplasia: a systematic review and meta-analysis. Hypertension 2010; 56: 525-532.
46. Tendera M., Aboyans V., Bartelink M.L. et al.: ESC Guidelines on the diagnosis and treatment of peripheral artery diseases: Document covering atherosclerotic disease of extracranial carotid and vertebral, mesenteric, renal, upper and lower extremity arteries: the Task Force on the Diagnosis and Treatment of Peripheral Artery Diseases of the European Society of Cardiology (ESC). Eur. Heart J. 2011; 32: 2851-2906.
47. Hirsch A.T., Haskal Z.J., Hertzer N.R. et al.: ACC/AHA 2005 Practice Guidelines for the management of patients with peripheral arterial disease (lower extremity, renal, mesenteric, and abdominal aortic): a collaborative report from the American Association for Vascular Surgery/Society for Vascular Surgery, Society for Cardiovascular Angiography and Interventions, Society for Vascular Medicine and Biology, Society of Interventional Radiology, and the ACC/AHA Task Force on Practice Guidelines (Writing Committee to Develop Guidelines for the Management of Patients With Peripheral Arterial Disease): endorsed by the American Association of Cardiovascular and Pulmonary Rehabilitation; National Heart, Lung, and Blood Institute; Society for Vascular Nursing; TransAtlantic Inter-Society Consensus; and Vascular Disease Foundation. Circulation 2006; 113: e463-e654.
48. Stanowisko grupy ekspertów dotyczące diagnostyki obrazowej i wskazań do wykonywania zabiegów przezskórnej angioplastyki zwężenia tętnicy nerkowej u chorych z nadciśnieniem tętniczym przyjęte przez Polskie Towarzystwo Nadciśnienia Tętniczego, Polskie Towarzystwo Nefrologiczne. Nadciśnienie Tętnicze 2009; 13: 1-9.